| (USD) | Jan 2024 | Q/Q |
|---|---|---|
| Revenue | 630.6MM | +2% |
| Gross Profit | 456.7MM | +2% |
| Cost Of Revenue | 173.9MM | +4% |
| Operating Income | 135.3MM | +5% |
| Operating Expenses | 321.4MM | +0% |
| Net Income | 147.4MM | +9% |
| R&D | 163.6MM | +1% |
| G&A | 58.7MM | -6% |
| Marketing | 99.2MM | +3% |
| Amortization | 4MM | -20% |
Short Volume Ratio = Short Volume / All Volume. Source of Short Volume data comes from
FinraMoving Average Convergence/Divergence oscillator (MACD) is one of the simplest and most effective momentum indicators available.
Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. RSI oscillates between zero and 100. According to Wilder, RSI is considered overbought when above 70 and oversold when below 30.
Veeva (VEEV) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Veeva (VEEV) announces the Veeva AI Partner Program, which is expected to provide partners assistance to combine Generative AI solutions with Veeva Vault applications.
Veeva Systems Inc. ( NYSE:VEEV ) shareholders might be concerned after seeing the share price drop 12% in the last...
Veeva Systems (VEEV) closed the most recent trading day at $201.10, moving +1.02% from the previous trading session.
Veeva Systems (NYSE: VEEV) today announced that 16 of the top 20 biopharmas are increasing media efficiency with Veeva Crossix Prime Segments, privacy-safe data helping life sciences brands reach highly-qualified health audiences. Since launching in April 2023, Veeva Crossix Prime Segments have helped top biopharmas reach consumers that are 10 times more qualified than standard health audience segments through digital media campaigns.
Veeva Systems (NYSE:VEEV) has had a rough month with its share price down 13%. However, a closer look at its sound...
Veeva Systems (NYSE: VEEV) today announced the Veeva AI Partner Program to provide partners with the advanced technology and support needed to integrate Generative AI (GenAI) solutions seamlessly with Veeva Vault applications.
In the latest trading session, Veeva Systems (VEEV) closed at $199.20, marking a -0.58% move from the previous day.
Veeva Systems (NYSE: VEEV) today announced Veeva Vault CRM Campaign Manager, a new industry-specific marketing application that simplifies and speeds non-personal promotion to healthcare professionals. Vault CRM Campaign Manager lives in the same Vault as Veeva Vault CRM and shares the same customer data, giving sales and marketing the effortless synchronization needed for true customer centricity. Through orchestrated campaigns, marketing users in Vault CRM work side by side with field CRM user
Veeva Systems (NYSE: VEEV) today announced that leaders from Bayer, Genentech, Novo Nordisk, Takeda, and others will be among the keynote speakers at the 2024 Veeva Commercial Summit, May 7-8 in Boston. Commercial and medical affairs professionals will share how they are innovating across content, data and analytics, and customer interactions to advance the future of customer-centric engagement.